We are live on ! Find out more
ONCY

Oncolytics Biotech
ONCY

51 hedge funds and large institutions have $756K invested in Oncolytics Biotech in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

114% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 7

11% more funds holding

Funds holding: 46 → 51 (+5)

0.11% less ownership

Funds ownership: 1.71% → 1.59% (-0.11%)

37% less capital invested

Capital invested by funds: $1.21M → $756K (-$450K)

Holders
51
Holders Change
+5
Holders Change %
+10.87%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
15
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$37K
2
BPWM
Badgley Phelps Wealth Managers
Washington
+$29.3K
3
BCWM
Ball & Co Wealth Management
Tennessee
+$23.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$14.6K
5
TSS
Two Sigma Securities
New York
+$11.1K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$90K
2
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$43.7K
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$7.13K
4
Morgan Stanley
Morgan Stanley
New York
-$4.02K
5
BHWM
Beaird Harris Wealth Management
Texas
-$754
Name Holding Trade Value Shares
Change 		Change in
Stake
GSC
26
Ground Swell Capital
South Carolina
$7.97K +$10.6K +14,493 New
AFP
27
Ausdal Financial Partners
Iowa
$7.92K -$439 -600 -4%
PCA
28
Prosperity Capital Advisors
Ohio
$7.91K – – –
Creative Planning
29
Creative Planning
Kansas
$7.33K – – –
PI
30
PFG Investments
New York
$7.11K +$1.46K +2,000 +18%
KWM
31
Kingsview Wealth Management
Oregon
$6.17K -$578 -790 -7%
IFG
32
Independent Financial Group
California
$6.08K +$8.11K +11,081 New
AF
33
Allworth Financial
California
$4.93K – – –
TRCT
34
Tower Research Capital (TRC)
New York
$4.24K +$5.64K +7,717 New
CMA
35
Cedar Mountain Advisors
Oregon
$3.11K – – –
VNA
36
Valley National Advisers
Pennsylvania
$3K +$4.28K +5,850 New
AWM
37
Activest Wealth Management
Florida
$2.75K – – –
National Bank of Canada
38
National Bank of Canada
Quebec, Canada
$2.57K -$43.7K -59,816 -93%
Wells Fargo
39
Wells Fargo
California
$2.42K – – –
Osaic Holdings
40
Osaic Holdings
Arizona
$1.82K +$924 +1,263 +62%
BlackRock
41
BlackRock
New York
$1.65K – – –
IA
42
IFP Advisors
Florida
$1.43K +$70 +96 +4%
Carson Wealth (CWM LLC)
43
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
SPIA
44
Steward Partners Investment Advisory
New York
$550 – – –
MCM
45
MAI Capital Management
Ohio
$290 – – –
TWC
46
TD Waterhouse Canada
Ontario, Canada
$209 -$115 -157 -28%
JFA
47
JNBA Financial Advisors
Minnesota
$116 – – –
SIS
48
Sound Income Strategies
Florida
$107 +$142 +194 New
DWM
49
Dogwood Wealth Management
Kansas
$80 – – –
AF
50
Aviso Financial
Ontario, Canada
$28 – – –
1
2
3

ONCY Hedge Fund Activity: Q1 2025 in Review

51 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q1 2025, worth a combined $756K — down 37% from $1.21M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ONCY positions and 3 closed out — a net gain of 5 holders — while 15 added to existing stakes and 7 trimmed.

The largest buyer was Franklin Resources, adding an estimated $37K. The largest seller was Virtu Financial, exiting entirely with an estimated $90K sold.

  • 51 institutional investors held Oncolytics Biotech (ONCY) as of Q1 2025, up from 46 in Q4 2024.
  • Funds reported $756K of Oncolytics Biotech stock for Q1 2025, down 37% quarter-over-quarter.
  • 8 funds opened new Oncolytics Biotech positions in Q1 2025 and 3 closed out, a net change of +5 holders.
  • The largest Oncolytics Biotech buyer in Q1 2025 was Franklin Resources, an estimated $37K added.
  • The largest Oncolytics Biotech seller in Q1 2025 was Virtu Financial, an estimated $90K sold.

Based on aggregated 13F filings for Q1 2025.